The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Exotic emerging viral diseases: progress and challenges
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., & Liotta, L. A. (1996) · Science · doi:10.1126/science.274.5289.998 · Cited by 2,534
McCormick, J. B., King, I. J., Webb, P. A., Scribner, C. L., Craven, R. B., Johnson, K. M., Elliott, L. H., & Belmont-Williams, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601023140104 · Cited by 999
Laser Capture Microdissection: Molecular Analysis of Tissue
Bonner, R. F., Emmert-Buck, M., Cole, K., Pohida, T., Chuaqui, R., Goldstein, S., & Liotta, L. A. (1997) · Science · doi:10.1126/science.278.5342.1481 · Cited by 874
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Cao, W., Henry, M. D., Borrow, P., Yamada, H., Elder, J. H., Ravkov, E. V., Nichol, S. T., Compans, R. W., Campbell, K. P., & Oldstone, M. B. A. (1998) · Science · doi:10.1126/science.282.5396.2079 · Cited by 695
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans
Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., & Delgado, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6841-6844.2002 · Cited by 652
Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
Self-citationBaize, S., Leroy, E. M., Georges-Courbot, M.-C., Capron, M., Lansoud-Soukate, J., Debré, P., Fisher-Hoch, S. P., McCormick, J. B., & Georges, A. J. (1999) · Nature Medicine · doi:10.1038/7422 · Cited by 551
Monath, T. P. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00016-0 · Cited by 534
Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K., & Yagita, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1451 · Cited by 479
The Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Mühlberger, E., Bray, M., Klenk, H.-D., Palese, P., & García-Sastre, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7945-7956.2003 · Cited by 477
Ebola haemorrhagic fever in Zaire
Otatume, S. (1996) · Journal of African Studies · doi:10.11619/africa1964.1996.49_95 · Cited by 474
Bwaka, M. A., Bonnet, M., Calain, P., Colebunders, R., De Roo, A., Guimard, Y., Katwiki, K. R., Kibadi, K., Kipasa, M. A., Kuvula, K. J., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514308 · Cited by 465
The Reemergence of Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995
Khan, A. S., Tshioko, F. K., Heymann, D. L., Le Guenno, B., Nabeth, P., Kerstiëns, B., Fleerackers, Y., Kilmarx, P. H., Rodier, G. R., Nkuku, O., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514306 · Cited by 463
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z.-Y., Roederer, M., Koup, R. A., Jahrling, P. B., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature01876 · Cited by 462
Self-citationInhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 444
Calandra, T., Gerain, J., Heumann, D., Baumgartner, J.-D., & Glauser, M. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90069-a · Cited by 442
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
Mupapa, K., Massamba, M., Kibadi, K., Kuvula, K., Bwaka, A., Kipasa, M., Colebunders, R., Muyembe‐Tamfum, J. J., & the International Scientific and Technical Committee (1999) · The Journal of Infectious Diseases · doi:10.1086/514298 · Cited by 420
Nabel, G. J., Yang, Z., Duckers, H. J., Sullivan, N. J., Sanchez, A., & Nabel, E. G. (2000) · Nature Medicine · doi:10.1038/78645 · Cited by 413
Human asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
Geisbert, T. W., Hensley, L. E., Jahrling, P. B., Larsen, T., Geisbert, J. B., Paragas, J., Young, H. A., Fredeking, T. M., Rote, W. E., & Vlasuk, G. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15012-x · Cited by 382
Self-citationBouloy, M., Janzen, C., Vialat, P., Khun, H., Pavlovic, J., Huerre, M., & Haller, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1371-1377.2001 · Cited by 381
Marzi, A., Gramberg, T., Simmons, G., Möller, P., Rennekamp, A. J., Krumbiegel, M., Geier, M., Eisemann, J., Turza, N., Saunier, B., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12090-12095.2004 · Cited by 377
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003) · The Journal of Infectious Diseases · doi:10.1086/379724 · Cited by 372
Self-citationSimmons, G., Reeves, J. D., Grogan, C. C., Vandenberghe, L. H., Baribaud, F., Whitbeck, J. C., Burke, E., Buchmeier, M. J., Soilleux, E. J., Riley, J. L., et al. (2003) · Virology · doi:10.1006/viro.2002.1730 · Cited by 369
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P. E., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2797 · Cited by 354
A case of Ebola virus infection.
Emond, R. T., Evans, B., Bowen, E. T., & Lloyd, G. (1977) · BMJ · doi:10.1136/bmj.2.6086.541 · Cited by 353
Outbreake of Marburg virus disease in Johannesburg
Gear, J. S., Cassel, G. A., Gear, A. J., Trappler, B., Clausen, L., Meyers, A. M., Kew, M. C., Bothwell, T. H., Sher, R., Miller, G. B., et al. (1975) · BMJ · doi:10.1136/bmj.4.5995.489 · Cited by 352
(1999) · Choice Reviews Online · doi:10.5860/choice.37-0912 · Cited by 350
Maiztegui, J., Fernandez, N., & De Damilano, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92335-3 · Cited by 332
Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
Geisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Larsen, T., Kagan, E., & Hensley, L. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63592-4 · Cited by 318
Self-citationEffect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity
Neumann, F.-J., Ott, I., Marx, N., Luther, T., Kenngott, S., Gawaz, M., Kotzsch, M., & Schömig, A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3399 · Cited by 308
Villinger, F., Rollin, P. E., Brar, S. S., Chikkala, N. F., Winter, J., Sundstrom, J. B., Zaki, S. R., Swanepoel, R., Ansari, A. A., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 307
Volchkov, V. E., Volchkova, V. A., Mühlberger, E., Kolesnikova, L. V., Weik, M., Dolnik, O., & Klenk, H.-D. (2001) · Science · doi:10.1126/science.1057269 · Cited by 303
Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302
Self-citationSanchez, A., Lukwiya, M., Bausch, D., Mahanty, S., Sanchez, A. J., Wagoner, K. D., & Rollin, P. E. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10370-10377.2004 · Cited by 281
Jahrling, P. B., Geisbert, T. W., Geisbert, J. B., Swearengen, J. R., Bray, M., Jaax, N. K., Huggins, J. W., LeDuc, J. W., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514310 · Cited by 269
Self-citationProtective Efficacy of a Live Attenuated Vaccine against Argentine Hemorrhagic Fever
Maiztegui, J. I., McKee, Jr., Oro, J. G. B., Harrison, L. H., Gibbs, P. H., Feuillade, M. R., Enria, D. A., Briggiler, A. M., Levis, S. C., Ambrosio, A. M., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514211 · Cited by 263
Crimean Congo-Haemorrhagic Fever treated with oral ribavirin
Khan, J. A., Rehman, S., Fisher-Hoch, S. P., Mirza, S., Khurshid, M., & McCormick, J. B. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91323-8 · Cited by 259
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
Feldmann, H., Bugany, H., Mahner, F., Klenk, H. D., Drenckhahn, D., & Schnittler, H. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2208-2214.1996 · Cited by 256
Takada, A., Fujioka, K., Tsuiji, M., Morikawa, A., Higashi, N., Ebihara, H., Kobasa, D., Feldmann, H., Irimura, T., & Kawaoka, Y. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2943-2947.2004 · Cited by 251
Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
Geisbert, T. W., Pushko, P., Anderson, K., et al. (2002) · Emerging infectious diseases · doi:10.3201/eid0805.010284 · Cited by 248
Self-citationHensley, L. (2002) · Immunology Letters · doi:10.1016/s0165-2478(01)00327-3 · Cited by 242
Lassa Virus Infection of Rhesus Monkeys: Pathogenesis and Treatment with Ribavirin
Jahrling, P. B., Hesse, R. A., Eddy, G. A., Johnson, K. M., Callis, R. T., & Stephen, E. L. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/141.5.580 · Cited by 231
Self-citationGrignani, G., & Maiolo, A. T. (2000) · PubMed · Cited by 227
[The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note].
Brès, P. (1978) · Europe PMC (PubMed Central) · Cited by 225
MARTY, C., MISSET, B., TAMION, F., FITTING, C., CARLET, J., & CAVAILLON, J.-M. (1994) · Critical Care Medicine · doi:10.1097/00003246-199404000-00025 · Cited by 212
Neumann, G., Feldmann, H., Watanabe, S., Lukashevich, I. S., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.406-410.2002 · Cited by 211
Pathologic and virologic study of fatal Lassa fever in man.
Walker, D. H., McCormick, J. B., Johnson, K. M., Webb, P. A., Komba-Kono, G., Elliott, L., & Gardner, J. J. (1982) · PubMed Central · Cited by 210
Burt, F. J., Swanepoel, R., Shieh, W., Smith, J. F., Leman, P. A., Greer, P. W., Coffield, L. M., Rollin, P. E., Ksiazek, T. G., Peters, C., et al. (1997) · PubMed · Cited by 210
Baize, S., Kaplon, J., Faure, C., Pannetier, D., Georges-Courbot, M. C., & Deubel, V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2861 · Cited by 208
Targeting the Function of Mature Dendritic Cells by Human Cytomegalovirus
Raftery, M. J., Schwab, M., Eibert, S. M., Samstag, Y., Walczak, H., & Schönrich, G. (2001) · Immunity · doi:10.1016/s1074-7613(01)00239-4 · Cited by 208
Spiropoulou, C. F., Kunz, S., Rollin, P. E., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5140-5146.2002 · Cited by 193
Enria, D. A., Fernandez, N., Briggiler, A., Levis, S., & Maiztegui, J. I. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90299-x · Cited by 183
Gallaher, W. R., DiSimone, C., & Buchmeier, M. J. (2001) · BMC Microbiology · doi:10.1186/1471-2180-1-1 · Cited by 172
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus
Becker, S., Spiess, M., & Klenk, H.-D. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-2-393 · Cited by 171
Current understanding of disseminated intravascular coagulation
Levi, M. M. (2004) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04790.x · Cited by 168
Ebola Hemorrhagic Fever and Pregnancy
Mupapa, K., Mukundu, W., Bwaka, M. A., Kipasa, M., Roo, A. D., Kuvula, K., Kibadi, K., Massamba, M., Ndaberey, D., Colebunders, R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514289 · Cited by 166
Pathologic Features of Filovirus Infections in Humans
Zaki, S. R., & Goldsmith, C. S. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59949-1_7 · Cited by 166
Déchanet‐Merville, J., Merville, P., Bergé, F., Bone‐Mane, G., Taupin, J., Michel, P., Joly, P., Bonneville, M., Potaux, L., & Moreau, J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314568 · Cited by 163
Salas, R., Pacheco, M. E., Ramos, B., Taibo, M. E., Jaimes, E., Vasquez, C., Querales, J., de Manzione, N., Godoy, O., Betancourt, A., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91899-6 · Cited by 163
Reed, D. S., Hensley, L. E., Geisbert, J. B., Jahrling, P. B., & Geisbertl, T. W. (2004) · Viral Immunology · doi:10.1089/vim.2004.17.390 · Cited by 157
Self-citationEbola Virus Haemorrhagic Fever
Halstead, S. B. (1979) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1979.28.775 · Cited by 155
Treatment of Bolivian Hemorrhagic Fever with Intravenous Ribavirin
Kilgore, P. E., Ksiazek, T. G., Rollin, P. E., Mills, J. N., Villagra, M. R., Montenegro, M. J., Costales, M. A., Paredes, L. C., & Peters, C. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.718 · Cited by 154
Wang, Q., Miyakawa, Y., Fox, N. E., & Kaushansky, K. (2000) · Blood · doi:10.1182/blood.v96.6.2093 · Cited by 139
Lukashevich, I. S., Maryankova, R., Владыко, А. С., Nashkevich, N., Koleda, S., Djavani, M. M., Horejsh, D., Voitenok, N. N., & Salvato, M. S. (1999) · Journal of Medical Virology · Cited by 138
Miura, Y., Misawa, N., Maeda, N., Inagaki, Y., Tanaka, Y., Ito, M., Kayagaki, N., Yamamoto, N., Yagita∥, H., Mizusawa, H., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.651 · Cited by 134
Monitoring of clinical and laboratory data in two cases of imported Lassa fever
SCHMITZ, H. E., Köhler, B., Laue, T., Drosten, C., Veldkamp, P. J., Günther, S., Emmerich, P., Geisen, H. P., Fleischer, K., Beersma, M. F. C., et al. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(01)01508-8 · Cited by 128
Volchkov, V. E., Blinov, V. M., & Sv, N. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80662-z · Cited by 122
Rubins, K., Hensley, L. E., Jahrling, P. B., Whitney, A. R., Geisbert, T. W., Huggins, J. W., Owen, A. B., LeDuc, J. W., Brown, P. O., & Relman, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405759101 · Cited by 121
Self-citationHuggins, J., Zhang, Z., & Bray, M. (1999) · The Journal of Infectious Diseases · doi:10.1086/514316 · Cited by 116
Lassa fever A study of 23 hospital cases
White, H. A. (1972) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(72)90269-6 · Cited by 115
(1971) · Springer eBooks · doi:10.1007/978-3-662-01593-3 · Cited by 104
Pathogenesis of Viral Hemorrhagic Fevers: Rift Valley Fever and Lassa Fever Contrasted
Peters, C. J., Lin, C.-T., Anderson, G. W., et al. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_4.s743 · Cited by 101
Experimental Rift Valley fever in rhesus macaques
Peters, C. J., Jones, D., Trotter, R. W., Donaldson, J., White, J., Stephen, E. L., & SLONE, T. W. (1988) · Archives of Virology · doi:10.1007/bf01311021 · Cited by 100
Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response
Morrill, J. C., Jennings, G. B., Johnson, A. J., Cosgriff, T. M., Gibbs, P., & Peters, C. J. (1990) · Archives of Virology · doi:10.1007/bf01311288 · Cited by 93
Are all Type I human interferons equivalent?
Foster, G. R., & Finter, N. B. (1998) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1998.00103.x · Cited by 93
Marburg Hemorrhagic Fever: Report of a Case Studied by Immunohistochemistry and Electron Microscopy
Geisbert, T. W., & Jaax, N. K. (1998) · Ultrastructural Pathology · doi:10.3109/01913129809032253 · Cited by 92
Self-citationAsper, M., Sternsdorf, T., Haß, M., Drosten, C., Rhode, A., SCHMITZ, H. E., & Günther, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3162-3169.2004 · Cited by 88
Prevention of Rift Valley Fever in Rhesus Monkeys with Interferon-α
Morrill, J. C., Jennings, G. B., Cosgriff, T. M., Gibbs, P., & Peters, C. J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_4.s815 · Cited by 85
Disseminated Intravascular Coagulation (DIC)
Vohr, H.-W. (2015) · Springer eBooks · doi:10.1007/978-3-642-54596-2_200391 · Cited by 83
Fisher‐Hoch, S. P., & McCormick, J. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.2.189 · Cited by 81
Marburg Virus Disease. Clinical Syndrome
Martini, G. A. (1971) · Springer eBooks · doi:10.1007/978-3-662-01593-3_1 · Cited by 77
Marburg virus infection in monkeys. Ultrastructural studies.
Fa, M., Simpson, D. I., Whitfield, S. G., Zlotnik, I., & Gb, C. (1971) · PubMed · Cited by 74
Khan, A. S., Ksiazek, T. G., & Peters, C. J. (1997) · Seminars in Pediatric Infectious Diseases · doi:10.1016/s1045-1870(97)80011-8 · Cited by 66
A hitherto unknown infectious disease contracted from monkeys. "Marburg-virus" disease.
Martini, G. A., Knauff, H. G., Schmidt, H., Mayer, G., & Baltzer, G. (1968) · PubMed · Cited by 65
Towards a vaccine against Ebola virus
Geisbert, T., & Jahrling, P. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.6.777 · Cited by 51
Self-citationEndothelial cell function alteration after Junin virus infection
Gomez, R. M., Pozner, R. G., Lazzari, M. A., D’Atri, L. P., Negrotto, S., Chudzinski‐Tavassi, A. M., Berría, M. I., & Schattner, M. A. (2003) · Thrombosis and Haemostasis · doi:10.1160/th02-09-0043 · Cited by 51
Bukreyev, A. A., Volchkov, V. E., Blinov, V. M., & Sv, N. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81476-g · Cited by 47
Clayton, A. (1977) · Europe PMC (PubMed Central) · Cited by 33
The pathology of Marburg virus disease.
Rippey, J. J., Schepers, N. J., & GEAR, J. H. S. (1984) · PubMed · Cited by 32
The Pathology of the Spleen in Yellow Fever.
KLOTZ, O., & Belt, T. H. (1930) · PubMed · Cited by 24
Pathologic Anatomy of the Marburg Virus Disease
Gedigk, P., Bechtelsheimer, H., & Korb, G. (1971) · Springer eBooks · doi:10.1007/978-3-662-01593-3_7 · Cited by 13
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Cited by
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
The pig: a model for human infectious diseases
Meurens, F., Summerfield, A., Nauwynck, H., Saif, L., & Gerdts, V. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2011.11.002 · Cited by 999
Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies
Gowen, B. B., & Hickerson, B. T. (2017) · Journal of Microbiology · doi:10.1007/s12275-017-7029-8 · Cited by 26
Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents
Chang, J., Guo, J.-T., Du, Y., & Block, T. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.77 · Cited by 22
Metadata
- Authors
- Geisbert, T. W., & Jahrling, P. B.
- Venue
- Nature Medicine
- Published
- 2004-11-30
- Volume
- 10
- Issue
- S12
- Pages
- S110-S121
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2085818819
- Cited by
- 441
- References
- 97
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.